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ABSTRACT 
Balchaturbhadra churna is a poly-herbal formulation used in pediatric practice in Ayurveda 
especially in the treatment of vomiting, diarrhea, fever and respiratory disorders. The human 
clinical dose of Balchaturbhadra churna is 1000 mg per day. It is prepared by mixing equal 
proportions of rhizome of Cyperus rotundus Linn. (Cyperaceae), fruit of Piper longum Linn. 
(Piperaceae), root of Aconitum heterophyllum Wall. ex. Royale. (Ranunculaceae) and gall of Pistacia 
integerrima Stew. Ex. Brandis. (Anacardiaceae). Aims and objectives: Critical analysis of 
Balchaturbhadra churna in management of childhood disorder. Material and Methods: Various 
Ayurveda classics and studies published in journals related to use of Balchaturbhadra churna in 
management of childhood disorder are reviewed and analyzed. Discussion: Contents of 
Balchaturbhdra churna are mostly Katu rasa, Laghu guna, Usna veerya and also Deepana, Pachana, 
Krimighna, Visaghna, Hridya, Ruchya, Vrisya, Rasayana, Rochana, Sthoulyahara, Trisnanigrahana, 
Tvakadosahara, Jwaraghna etc. properties. Therefore due to presence of these qualities, it is used 
in vomiting, diarrhea, fever and respiratory disorders. According to studies published in journals, 
it is beneficial as immuno-modulator, anti inflammatory, anti spasmodic, anti asthmatic activity, 
anti bacterial activity, antidiabetic activity, antioxidant activity, anti-fungal activity, 
hepatoprotective action, analgesic activity.  Conclusion: Present review reveals Balchaturbhadra 
churna is quite safe for administration among Children and therefore can be used in various 
ailments in children which can limit the irrational use of antibiotics in them. 
KEYWORDS: Balchaturbhadrachurna, Ayurveda, Cyperus rotundus, Piper longum, Aconitum 
heterophyllum, Pistacia integerrima. 
INTRODUCTION 
Antibiotic resistance is posing the greatest 
challenge to medical science. Irrational use of 
antibiotics has led the Children being more 
vulnerable, special cares have to be taken in selecting 
the drugs and formulations. Balchaturbhadra churna 
is a poly-herbal formulation used in pediatric 
practice in Ayurveda especially in the treatment of 
vomiting, diarrhea, fever, and respiratory disorders 
which are the most common childhood morbidities. 
The human clinical dose of Balchaturbhadra churna is 
1000 mg per day. It is prepared by mixing equal 
proportions of the rhizome of Musta (Cyperus 
rotundus) Linn. (Cyperaceae), fruits of Pippali (Piper 
longum) Linn. (Piperaceae), roots of Ativisha 
(Aconitum heterophyllum) Wall. ex. Royale. 
(Ranunculaceae) and gall of Karkatashringi (Pistacia 
integerrima Stew.) Ex. Brandis. (Anacardiaceae). [1] 
It is mentioned in various classical Ayurveda, 
like Chakradatta, [2] Bhaishajya ratnavali [3] and Yog 
ratnakar, [4] specifically indicated for respiratory 
diseases, vomiting, diarrhea and fever in children. 
As there is increasing tendency of irrational use of 
antibiotics in children, this has led to the 
development of superbugs which do not respond to 
antibiotics and are posing the greatest challenge to 
conventional medicines. Balchaturbhadra churna is 
quite effective in various childhood disorders and if 
used in children can minimize the use of antibiotics. 
The present paper reviews the effect of 
Balchaturbhadra churna on childhood disorders and 
provides the clinical and experimental evidences for 
the same. 
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Aim  
To study the effect of Balchaturbhadra churna 
in childhood diseases with evidences. 
Methodology 
Present paper reviews the indications and 
uses of Balchaturbhadra churna described in 
Ayurveda texts. Studies published in various journals 
regarding the evidences of its effect are also 
reviewed. Clinical and experimental efficacy of each 
ingredient are reviewed and discussed here. 
Table 1: Ingredients and the part used of Balchaturbhadra churna 
Name of drug  Botanical name  Family Part used  Proportion  
Musta  Cyperus rotundus Linn.  Cyperaceae Rhizome  1 part  
Pippali  Piper longum Linn.  Piperaceae Fruit  1 part  
Ativisha  Aconitum heterophyllum Wall.  Aconitaceae Root  1 part  
Karkatashringi  Pistacia integerrima Stew.  Liliaceae Gall  1 part 
Table 2: Pharmacological properties of the contents of Balchaturbhadra churna as per Ayurveda 
S.N.  Drug Name  Rasa  Guna  Virya  Vipaka  Doshaghnata  Karma Therapeutic uses 
1  Musta [5] 
(Cyperus 
rotundus)  
Tikta, 
Katu.  
Laghu  Sheeta  Madhura
/Katu  
Kaphahara  
Pittahara  
Sothahara[6] 
(anti-
inflammatory), 
Deepana 
(increases 
digestive fire), 
Pachana 
(digests 
undigested 
material), Grahi 
(absorbing), 
Jwaraghna 
(Anti-pyretic), 
Atisaraghna 
(Anti-diarrheal) 
[7-9] 
Ajeerna[10-11] 
(Indigestion),  
Aruchi (tastelessness), 
Atisara (Diarrhea), [12] 
Jwara (Fever), Kasa 
(Cough)[13-14]   Shwasa 
(Asthma), Vamana 
(Vomiting), Vatarakta 
(Gout) [15]  
2  Ativisha [16] 
(Aconitum 
heterophyllum) 
Tikta, 
Katu.  
Laghu  Ushna  Katu  Kaphahara  
Pittahara  
Deepana 
(increases 
digestive fire), 
Pachana 
(digests 
undigested 
material), Grahi 
(absorbing) [17]    
Jwara (Fever), Chardi 
(vomiting), Atisara 
(diarrhea), Shoth 
(inflammation), Visha 
(poisoning), Ageerna 
(indigestion), Kasa 
(Cough) [18-20] 
3  Katrkatshrung
i [21] (Pistacia 
integerrima) 
Tikta, 
Kashaya  
Laghu  Ushna  Katu  Kaphahara  
Vatahara  
Kasahara [22] 
(anti-tussive), 
Hikkanigrahana 
(anti-hiccup) [23] 
Svasa (asthma), Chardi 
(vomiting), Hikka 
(hiccup), Jvara (Fever), 
Kasa (Cough) [24] 
4  Pippali [25] 
(Piper 
longum) 
Katu  Ushna, 
Snigdh
aLaghu  
Ushna  Madhura  Kaphahara  
Vatahara  
Deepana [26] 
(increases 
digestive fire), 
Hridya [27] 
(heart disease) 
 
Arsa  (hemorrhoid), 
Hikka (hiccup), Kasa 
(cough), Prameha 
(diabeties),  
Udara Roga 
(abdominal pain), Jvara 
(fever) [28] 
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Therapeutic uses of Balchaturbhadra Churna [29-31]  
Jvaratisara (fever & diarrhea), Kasa (cough), Svasa 
(asthma) and Vamana (vomiting). 
Evidences: Clinical And Experimental 
Musta (Cyperus rotundus) 
1. Antibacterial activities 
The methanol extract of cyperus rotundus 
studied for antibacterial activity in the 
microorganism stains of human pathogenic bacteria 
both gram positive and gram negative bacteria such 
as Bacillus subtilis, Staphylococcus aureus, Escherichia 
coli and Pseudomonas aeruginosa. The methanol 
extract of Cyperus roduntus flower showed highly 
antibacterial activity. [32] The ethanolic extract of the 
plant was active against all the investigated bacterial 
strains while the aqueous extract was inactive for S. 
typhimurium. The oil and its fractions hydrocarbon-I 
and II extracted from Cyperus rotundus alcohol 
fraction-cyperol was found to possess significant 
antibacterial effect against Staphylococcus Aureus. [33] 
The antibacterial activity of different extracts was 
determined by agar well-diffusion method. [34] The 
root extract of C. rotundus showed notable 
antibacterial activity against selected pathogens i.e. 
H. influenzae, P. aeruginosa, S. aureus, S. pneumoniae 
and S. pyogenes. An inhibitory effect of C. rotundus 
was observed against selected bacterial strains 
including S. aureus, Salmonella enteritidis and 
Enterococcus faecalis with total oligomers flavonoids 
and ethyl acetate extracts. [35] Tambekar et al, (2009) 
also reported that MeOH extract of the rhizomes of C. 
rotundus showed considerable antibacterial potential 
against S. aureus, K. pneumoniae, S. typhi, S. paratyphi, 
S. typhimurium, P. aeruginosa, E. aerogenes. [36]  In a 
study, maximum inhibition was found against H. 
influenzae (18.4±0.07 mm) followed by S. pyogenes 
(17.3±0.13mm), P. aeruginosa (16.2±0.07 mm) and S. 
pneumoniae (15.5±0.15 mm) and minimum against S. 
aureus (15.3±0.05 mm) respectively.[37] The C.  
rotundus extract had antibacterial effects 
(bactericide and bacteriostatic) on S. mutans and L. 
acidophillus. Although this effect was lower than 
CHX. With regard to adverse effect of CHX, this 
extract can be a potential antibacterial agent. [38] 
2. Anti-inflammatory Activity  
To evaluate the anti-inflammatory activity in 
adult albino wistar rats, C. rotundus extract of the 
tuber part was used. The test group was treated with 
ether, ethanol, and distilled water extract of three 
equal portions of the powder. The ethanolic extract 
showed good anti-inflammatory effect than other 
solvents system. [39] Phytochemical investigation of 
the methanolic extract of Cyperus rotundus L. 
(Cyperaceae) rhizomes afforded a new norterpenoid 
with an unprecedented carbon skeleton, namely 
cyperalin A (1) and sugetriol triacetate (2). The 
isolated compounds were evaluated for their anti-
inflammatory activity. [40] 
3. Immunomodulatory activity 
Immunomodulatory activity of extracted lectins 
from rhizome of Cyperus rotundus was evaluated on 
phagocytic activity by carbon clearance test on 
Albinos Wistar mice at dose of 25mg/kg by intra-
peritoneal injection (IP). The extracted lectins from 
rhizome of Cyperus rotundus exhibited significantly 
dose-dependent phagocytic index indicating 
stimulation of the reticulo-endothelial system. [41] In 
vitro tests on the ethanol extracts of C. rotundus 
rhizomes shows the extract inhibited leukotrienes 
production by 66–91% at 30–300 μg/ml. [42]  
4. Antioxidant Activity  
The evaluation of antioxidant property of 
ethanolic extract of Cyperus rotundus (EECR) was 
carried out by in vitro non-enzymatic glycosylation of 
hemoglobin method. [43] 
5. Anti-diarrheal Activity  
The aqueous extract of C. rotundus tubers shows 
anti-giardial activity against infectious diarrhea. [44] 
The decoction of C. rotundus tubers also showed anti-
diarrheal activity and effect on adherence of entero-
pathogenic E. coli, entero invasive E. coli and Shigella 
flexneri to Hep-2 cells. [45] 
6. Antiulcer Activity  
The antiulcer activity of C. rotundus tuber powder 
extract was investigated in two different animal 
models. The first one was histamine-induced ulcer in 
guinea pigs, and another one was aspirin-induced 
gastric mucosal damage in rats. In the both cases, the 
plant extract showed maximum reduction of ulcer 
which was comparable to ranitidine. [46] 
7. Antidiabetic Activity  
The antidiabetic activities of hydro alcoholic 
extract of C. rotundus rhizomes were studied on 
Sprague-Dawley rats. Alloxan monohydrate was 
administered intraperitonially to induce diabetes 
which showed significant rise in the blood glucose 
level. On the 15th day, after administration of the 
plant extract, the blood glucose level reduced as 
compared to the metformin. This observation 
suggests that the aqueous ethanolic extract of C. 
rotundus rhizomes have significant hypoglycemic 
activity. [47] 
8. Anti-allergic Activity 
Sesquiterpenes isolated from the ethanolic 
extract of the rhizomes of C. rotundus (CRE) were 
observed to possess anti-allergic activity. It was 
found that sesquiterpenes inhibited the 5-LOX 
catalyzed production of leukotrienes (LTs). Also they 
inhibited β-hexosaminidase release, as well as its 
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degranulation. The delayed type hypersensitivity 
reaction was also delayed by valencene and 
nootkatone present in the CRE. [48] 
9. Ovicidal and Larvicidal Effect  
The ovicidal and larvicidal effects of essential oil 
of C. rotundus extracted by hydrodistillation on eggs, 
and fourth instar larvae of Aedes albopietus were 
identified. It was obscured that the essential oil 
possesses ovicidal and larvicidal property when 
exposed to serial concentrations ranging from 5 to 
150 pmm. [49] 
Pippali (Piper longum) 
1. Antibacterial activity 
The essential oil of Piper longum showed 
antibacterial activity against B. cereus, B. subtilis, M. 
tuberculosis, Staph. albus, Staph. Aureus, and B. 
shigella dysenteriae, Esch.Coli, Sh. boydi, Sal. typhi and 
Vib. cholerae. The oil was more active than the oils of 
Alpinia galanga, Nigella sativa, Vateria indica and 
Saccopetalum tomentosum. [50] Dry roots of the 
plant Piper longum were extracted with n-hexane. 
The constituents were isolated and purified by 
column chromatography. The structures of the 
isolated constituents were confirmed by spectral 
analysis. The isolated constituents and n-hexane 
extract were found to show varying degree of 
antibacterial activity against all the tested bacteria. 
However, the aqueous extract did not show 
antibacterial activity against the tested bacteria. The 
isolated constituents were found to show better 
activity profile than the n-hexane extract, which 
indicates that the isolated constituents might be 
responsible for the antibacterial activity. [51] 
2. Anti allergic activity 
In an experimental study, albino rats were 
sensitized with horse serum. The rats were treated 
with ethanolic extract of Pippali (Piper longum) for 
14 days. The result showed that the extract at 100 
and 200 mg/kg bodyweight inhibited degranulation 
of mast cells to an extent of 62.44 and 67.24 % 
respectively. [52] The milk extracts of the fruits of 
Pippali (Piper longum), reduced passive cutaneous 
anaphylaxis in rats and protected guinea pigs against 
antigen-induced bronchospasm. [53] The petroleum 
ether extract of P. longum produced respiratory 
stimulation in smaller doses in various species. [54]  
Morphine and pentobarbitone induced respiratory 
depression was antagonized by the extract. [55] 
3. Anti asthmatic activity 
The effect of petroleum ether, alcoholic extracts 
and decoction of the fruits of Pippali (Piper longum) 
was studied for antihistaminic activity on Guinea 
pigs. At the dose of 100 μ g/kg bodyweight the 
extracts significantly inhibited the release of 
histamine from mast cells. The extracts at 50, 100 
and 200 mg/kg bodyweight protected the animals 
from histamine induced bronchospasm. This effect 
was dose dependent and therefore Pippali (Piper 
longum) is supposed to prevent the development of 
bronchial asthma. [56] 
4. Immunomodulatory activity 
Haemaglutination titre, macrophages migration 
index (MMI) and phagocytic index (PI) in mice 
demonstrated immunostimulatory action of Piper 
longum fruits to be both specific and non specific. 
The effects was more prominent in lower doses (225 
mg/kg) and was marginally reduced when the dose 
was increased,” In another study, it was found to 
offer protection against externally induced stress,” A 
famous Ayurvedic compound containing long pepper, 
pippali rasayan was tested in mice infected with 
Giardia lamblia which was found to produce 
significant activation of macrophages as shown by an 
increased macrophage migration index (MMI) and 
phagocytic activity. [57] 
5. Antispasmodic action 
The crude extract of Piper longum as well as 
piplartine suppressed the ciliary movements of the 
esophagus of frog. These findings suggest that 
therapeutic efficacy in relieving cough could be due 
to the suppression of cough reflex. [58] Also the milk 
extract of P. longum effectively reduced passive 
cutaneous anaphylaxis in rats and guina pigs; 
protected guinea pigs against antigen induced 
bronchospasm. [59-60] 
6. Larvicidal Effect  
Some of the piper species, P. longum, P. 
guanacastensis and their bioactive constituents are 
reported to have remarkable larvicidal activity 
against various mosquito species such as Cx. pipiens 
pallens, Ae. aegypti, Ae. togoi and Ae. atropalpus. [61-
62] 
7. Anti-fungal activity 
The essential oil of Piper longum demonstrated 
anti-fungal activity against Aspergillus flavus, 
Trichoderma viridi, Curvularia lunata, Penicillium 
javanicum and P. striatu. [63] 
8. Anti-inflammatory activity 
A marked anti-inflammatory activity of Piper 
longum fruit decoction against carrageenin induced 
rat paw oedema was reported. [64] By Ammonium 
sulphate precipitation method a protein was isolated 
from Pippali (Piper longum). This protein showed 
anti-inflammatory, antioxidant and free radical 
scavenging activity in vitro. At a dose of 1000μg/ml 
the Pippali (Piper longum) showed maximum anti-
inflammatory activity which was similar to that of 
Diclofenac sodium. [65] Four different market samples 
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of each variety of Pippali were procured from 
different regions of India. The samples collected from 
South India which have given more extractive values 
were selected for screening of anti-inflammatory 
activity. Randomly selected animals were divided 
into four groups of six animals each. The test drugs 
were administered orally at a dose of 200 mg/kg and 
the activity was compared with standard anti-
inflammatory drugs in both models. [66]  
10. Antioxidant activity 
Using aqueous extract of Pippali (Piper longum) 
fruit, silver nanoparticles were synthesized. These 
nanoparticles showed powerful antioxidant activities. 
Furthermore this activity was found to be similar to 
the standard antioxidants like vitamin E and 
butylated hydroxyanisole (BHA). [67] 
11. Hepatoprotective activity 
In a study, ethanol, petroleum ether, solvent 
ether, ethyl acetate, butanol and butanone extracts of 
the fruits of pippali (Piper longum) were evaluated 
for their hepatoprotective activities in adult Wistar 
rats. The ethanolic and butanol fractions showed a 
significant hepatoprotective activity. The results 
were compared to control and Liv-52-treated rats. [68]  
Ativisha (Aconitum heterophyllum)  
1. Antibacterial activity 
Antibacterial activities are found against gram 
negative (diarrhea causing) bacteria Escherichia coli, 
Shigella fl exineri, Pseudomonas aeruginosa and 
Salmonella typhi. [69] A. hetrophyllum plant has been 
reported to hold antifungal, cytotoxic, antiviral and 
immune-stimulant properties along with anti 
bacterial properties.[70-72] The alkaloid extract 
Aconitum heterophyllum showed significant level of 
antibacterial activity against S. aureus, B. 
bronchiseptica, B. subtilis, P. putida and X. campestris 
at higher concentration of 100 μg/ disc. The alkaloid 
extracts showed bactericidal effect against S. aureus, 
B. bronchiseptica and B. subtilis, whereas 
bacteriostatic effect was observed against P. putida 
and X. campestris. [73] Two new aconitine-type 
norditerpenoid alkaloids 6-dehydroacetyl-
sepaconitine (1) and 13-hydroxylappaconitine (2), 
along with three known norditerpenoid alkaloids 
lycoctonine, delphatine and lappaconitine were 
isolated from the roots of the Aconitum 
heterophyllum Wall, both of which exhibited 
significant antibacterial activity. [74]  
2. Anti-inflammatory activity  
The anti-inflammatory and analgesic activities of 
higenamine (a plant-based alkaloid) were evaluated 
by measuring paw edema. It was found to possess 
significant anti-inflammatory activity in the dose 
range of 10-50 mg/kg and good analgesic activity at 
the dose of 200 mg/kg. [75] Also the ethanolic root 
extract of Aconitum heterophyllum demonstrated the 
anti-inflammatory properties comparable to 
diclofenac sodium at dose of 900 mg/kg. [76] 
3. Immunomodulatory activity 
The ethanolic extract of Aconitum heterophyllum 
tuber enhanced the phagocytic function and inhibited 
the humoral component of the immune system, 
therefore showing immunomodulatory activity. [77] 
4. Antioxidant activity 
In vitro antioxidant activity of root extract of 
Aconitum heterophyllum was found to be equal to 
Vitamin C and in an in vivo study root extract treated 
animals showed significant attenuation of 
biochemical parameters and histo-pathological 
changes of the kidney compared to glycerol treated 
group and it was found to be more significant with 
the extract at 500 mg/kg than 250mg/kg. [78] 
5. Immunomodulatory activity 
For treatment of chronic infections and 
immunological disorders, the immunobiological 
activity was investigated of certain medicinal plants 
commonly used in the Ayurvedic and Unani systems 
of medicine. The effect of an ethanolic extract of each 
drug was considered on delayed type 
hypersensitivity, humoral responses to sheep red 
blood cells, skin allograft rejection, and phagocytic 
activity of the reticulo-endothelial system in mice. 
Aconitum heterophyllum appeared to stimulate 
phagocytic function while inhibiting the humoral 
component of the immune system. [79]  
Karkatshrungi (Pistacia intergerrima stew. Ex. 
Brandis) 
1. Antibacterial activity  
The Pistacia integerrima, Cedrus deodara and 
Gymnema sylvestre are active against seven different 
microorganisms like Escherichia coli, Salmonella 
typhi, Klebsiella pneumoniae, Proteus vulgaris, 
Pseudomonas, Bacillus subtillis and Staphylococcus 
aureus by using disc diffusion method. properties of 
all the phytochemicals were present in Pistacia  
integerrima, so demonstrated higher antibacterial 
activity. Comparison of standard antibiotic 
(teracyclin) was done with efficacy of plant extract 
which showed variable inhibitory activity against 
each bacterium.[80] Escherichia coli, Klebsiella 
pneumoniae, Pseudomonas aeruginosa, Staphylo-
coccus aureus (S. aureus), methicillin resistant S. 
aureus and vancomycin resistant S. aureus along with 
standard bacterial strains were used. Significant 
inhibitions by gall extracts which were acquired by 
extraction procedures with five solvents had been 
recorded for these multiple drug resistance (MDR) 
bacteria. The galls extract with water and Chloroform 
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had shown greater antibacterial activity against 
bacteria.[81] The chloroform fractions of Debregeasia 
salicifolia & Toona ciliate, methanol fraction 
of Pistacia integerrima, and aqueous fraction of 
Aesculus indica are suitable for the development of 
novel antibacterial compounds. [82] 
2. Antiasthmatic activity  
A dose dependent effect on disruption rate of 
actively sensitized mesenteric mast cells of albino 
rats was demonstrated upon treatment with aqueous 
extract of galls when challenged with antigen (horse 
serum along with triple antigen vaccine). The 
significant protection against histamine aerosol-
induced bronchospasm in guinea pigs was shown 
with treatment of aqueous extract of galls for ten 
days and also showed the spasmolytic activity against 
histamine induced contractions in isolated guinea pig 
tracheal chain preparation. It demonstrated the 
antiasthmatic activity of aqueous extract of P. 
integerrima galls. [83] The anti-asthmatic activity of 
Pistacia integerrima may be attributed to reduction in 
TNF-α, IL-4, and IL-5 expression levels, and increase 
in AQP1 and AQP5 expression levels. [84] 
3. Antioxidant activity 
Essential oil of Pistacia integerrima J.L. Stewart ex 
Brandis galls (EOPI) was tested using in vitro studies 
such as antioxidant activity, mast cell degranulation, 
angiogenesis, isolated guinea pig ileum preparation 
and soyabean lipoxidase enzyme activity. In vivo 
studies showed airway hyper-responsiveness in 
ovalbumin in sensitized guinea pigs using spirometry 
and lipopolysaccharide-induced bronchial 
inflammation in rats. [85] The crude extract and sub 
fractions of Pistacia integerrima galls were evaluated 
for their antioxidant potential using ABTS and DPPH 
assays. [86] Acetone extract exhibited highest total 
phenolics contents (113.7 mg GAE/100g, FW) and 
antioxidant potential for ferric ion reduction (107.3 
μM GAE/100g, FW), phosphomolybdenum complex 
assay (99.32 μM AAE/100g, FW) and DPPH radical 
scavenging (91.89%). Fruit of P. integerrima was 
shown to have excellent properties of nutrients, 
minerals and antioxidants. Crude extracts 
P. integerrima showed noteworthy potential against 
free radicals and could be of immense significance in 
the prevention of different diseases related to free 
radicals. [87] 
4. Radical scavenging activity (DPPH)  
Ethyl acetate and Butanol fractions of P. 
integerrima are reported to be enriched with 
monoglycosides and polyglycosides which showed 
higher antiradical activity as compared to aqueous 
and ethanol extracts. The active phytoconstituents 
isolated from P. integerrima extract showed 
significant antioxidant activity. The flavonoids and 
phenolic compounds present in the extracts of P. 
integerrima leaves have good radical scavenging and 
xanthine oxidase inhibitory activity. [88]  
5. Anti-inflammatory effect 
Anti-inflammation and analgesic activities of six 
tretracyclic, triterpenoids, pistaci gerrimones A, B, C, 
D, E, and F isolated from gall of P. integerrima was 
demonstrated. Pistaci gerrimones C and D exhibited 
highly significant activities showing an inhibition of 
paw oedema between 30-70% at a dose, 5 mg/kg. [89] 
The extracts of Pistacia integerrima 50-200 mg/kg 
(p.o.) had modest activity against hind paw acute and 
chronic inflammation induced by formalin 
(P<0.01).[90] The flavonoids (1-4) isolated from the 
chloroform fraction of Pistacia integerrima galls had 
anti-hyperalgesic and anti-inflammtory effects. The 
pretreatment of flavonoids (1-4) elicited marked 
anti-inflammtory effects in carrageenan induced paw 
edema test in mice during various assessment times 
(1-5 h). [91]  
6. Analgesic activity 
Pistacia integerrima barks contain good analgesic 
properties. The analgesic properties of traditional 
medicine are recognized through biologically active 
compounds which are the secondary metabolites of 
plants such as glycosides, tannins, flavonoids, 
alkaloids, saponins which are responsible for 
therapeutic properties of the plants like analgesic, 
anti-inflammatory and antipyretic. Flavonoids are 
known to target prostaglandins involved in acute 
inflammation and pain perception and flavonoids 
have therefore been accounted for analgesic, anti-
inflammatory and antipyretic activities.[92] 
Pistacia integerrima extracts have anti-nociceptive 
and analgesic effects and did not reveal to have acute 
toxicity on oral administration. [93] 
Effect of Balchaturbhadra Churna 
The Balchaturbhadra Churna did not modify 
humoral antibody formation, relative weight of 
spleen and the thymus of albino rats to significant 
extent. Immunological odema represents cell 
mediated immune response hence it can be inferred 
that the Balchaturbhadra Churna produces significant 
suppression of cell mediated immunity which is 
direct correlation of delayed type hypersensitivity 
(DTH) response and do not influence humoral 
immune response. The observed effect may be the 
main mechanism for the efficacy of the drug in 
respiratory disorders (Parmar, et.al., 2011). 
Dose: 
The dose for the experimental study was 
calculated by extrapolating the clinical human dose of 
Balchaturbhadra churna (1000 mg per day) to an 
animal dose based on body surface area ratio by 
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using conversion factor of 0.018.[94] The histo-
pathological studies of 16 organs showed that 
Balchaturbhadra churna at 450 mg/kg, increased the 
cellularity in the thymus and spleen. Other organs 
exhibited normal cytoarchitecture suggesting that the 
preparation is devoid of serious organ degenerative 
potential at this dose level. At the higher dose of 900 
mg/kg changes were observed in the spleen, thymus, 
and testis. The white pulp (lymphatic tissue) of the 
spleen forms a sheath around the arteries. The 
stroma is a network of reticular fibers and phagocytic 
reticular cells or fixed macrophages. As in all 
lymphatic tissue, the meshes of the framework are 
filled with free lymphocytes of various sizes, 
distributed to form diffuse and nodular lymphatic 
tissue which vary continuously and reflect the 
reaction of lymphatic tissue to various generalized 
stimuli.[95] 
Toxicological Assessment of the drug [96] 
Acute toxicity test: Balchaturbhadra churna did not 
generate any signs or symptoms of toxicity or 
mortality up to a dose of 2000 mg/kg which is more 
than 20 times more than therapeutic equivalent dose 
in rats, obviously indicating that the formulation is 
suspect to induce any drastic toxic effect in spite of 
containing Aconitum heterophyllum.  
Long-term toxicity test: The effect of 
Balchaturbhadra churna on various parameters such 
as percentage change in body weight, on the 
hematological parameters, on serum biochemical 
parameters, on biochemical parameters, and 
histopathological studies showed no harmful effect 
and did not generate any adverse effect on the above 
parameters except heavy dosage which was very 
much larger than actual therapeutic dose. 
CONCLUSION 
Present review reveals that Balchaturbhadra 
churna is quite safe for administration among 
children and can provide better result in diseases of 
vomiting, diarrhea, fever and respiratory disorders 
both as prophylactic and curative medication due to 
its Katu rasa, Laghu guna and Usna virya according to 
Ayurveda. A large number of research studies reveal 
that constituents of Balchaturbhadra churna is 
beneficial as immuno-modulator, anti-inflammatory, 
anti spasmodic, anti asthmatic activity, anti bacterial 
activity, antidiabetic activity, antioxidant activity, 
anti-fungal activity, hepatoprotective action, 
analgesic activity. This undoubtedly solves the safety 
concerns related to the presence of Aconitum species 
drug in the formulation. Balchaturbhadrachurna is 
quite safe for administration among Children and 
therefore can be used in various ailments in children 
which can limit the irrational use of antibiotics in 
them. 
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